| PERIOD ENDING | 28-Mar-09 | 29-Mar-08 | 31-Mar-07 | | Total Revenue | 886,506 | 956,270 | 1,023,615 | | Cost of Revenue | 669,163 | 681,314 | 666,755 | | | Gross Profit | 217,343 | 274,956 | 356,860 | | | Operating Expenses | | Research Development | 170,778 | 207,362 | 184,979 | | Selling General and Administrative | 115,298 | 99,410 | 57,330 | | Non Recurring | 800,563 | 19,085 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (869,296) | (50,901) | 114,551 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 22,946 | 32,952 | (23,569) | | Earnings Before Interest And Taxes | (846,350) | (17,949) | 90,982 | | Interest Expense | 10,165 | 9,960 | 4,583 | | Income Before Tax | (856,515) | (27,909) | 86,399 | | Income Tax Expense | 42,109 | (33,655) | 2,983 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (898,624) | 5,746 | 83,416 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (898,624) | 5,746 | 83,416 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($898,624) | $5,746 | $83,416 |
|
0.29% Nasdaq 
Income Statement
